SCHEMBL25429595

SCHEMBL25429595

Cn1ccc(=O)c2ccc(-c3nccnc3Sc3ccc(C(F)(F)F)cc3)cc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 3/20 0.37
▸ MCHR1 Q99705 1/20 0.35
▸ KDM2B Q8NHM5 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.33
▸ SCN9A Q15858 4/20 0.32
▸ SCN5A Q14524 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ BRD4 O60885 2/20 0.31
▸ TDP2 O95551 1/20 0.31
▸ EPHX2 P34913 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25954052 0.86 TRPV1 (0.37) TRPV1MCHR1KDM2BKDM4CSCN9A
SCHEMBL30544122 0.86 TRPV1 (0.37) TRPV1MCHR1KDM2BKDM4CSCN9A
SCHEMBL25430689 0.81 PDE10A (0.42) TRPV1MCHR1KDM2BKDM4C
SCHEMBL25429043 0.77 SLC6A2 (0.38) TRPV1MCHR1SCN9ASCN5ACYP1A2
SCHEMBL25430317 0.77 HSD17B10 (0.53) TRPV1EPHX2MAPK1KIF11
SCHEMBL25430344 0.73 TRPV1 (0.41) TRPV1MAPK1KIF11
Hydrochloric Acid SCHEMBL10631649 0.72 KIF11 (0.47) SCN9ASCN5AKIF11
SCHEMBL25974048 0.71 TRPV1 (0.37) TRPV1KIF11
SCHEMBL25340553 0.70 KIF11 (0.50) TRPV1CYP1A2CYP3A4CYP2C9HPGD
SCHEMBL25341274 0.70 KIF11 (0.50) TRPV1HPGDMAPK1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback